Molecular monitoring of cerebrospinal fluid can predict clinical relapse in acute lymphoblastic leukemia with eosinophilia

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 5, 2003, Pages 601-605

  Nuñez, Cesar A ^a   Zipf, Theodore F ^a   Roberts, W Mark ^a   Medeiros, L Jeffrey ^a   Hayes, Kimberly ^a   Bueso Ramos, Carlos E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FLUDARABINE; HYDROCORTISONE; IFOSFAMIDE; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 3; JANUS KINASE; MELPHALAN; MESNA; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHEMOTHERAPY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; EOSINOPHILIA; GENE CLUSTER; GENE FUSION; GENE REARRANGEMENT; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PREDICTION; RECURRENT DISEASE; RELAPSE; SCHOOL CHILD; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

CEREBROSPINAL FLUID; CHILD; EOSINOPHILIA; FATAL OUTCOME; GENE EXPRESSION PROFILING; GENES, IMMUNOGLOBULIN; HUMANS; LEUKEMIA, B-CELL; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS;

EID: 17544402395     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Spitzer G, Garson OM. Lymphoblastic leukemia with marked eosinophilia: a report of two cases. Blood. 1973;42:377-384.
2. Fishel RS, Farnen JP, Hanson CA, et al. Acute lymphoblastic leukemia with eosinophilia. Medicine. 1990;69:232-243.
3. Hogan HF, Koss W, Murgo AJ, et al. Acute lymphoblastic leukemia with chromosomal 5;14 translocation and hypereosinophilia: case report and literature review. J Clin Oncol. 1987;5:382-390.
4. Parker D, Graham-Pole J, Malpas JS, et al. Acute lymphoblastic leukemia with eosinophilia and basophilia. Am J Pediatr Hematol Oncol. 1979;1:195-199.
5. Grimaldi JC, Meeker TC. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood. 1989;73:2081-2085.
6. Meeker TC, Hardy D, Willman C, Hogan T, Abrams J. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood. 1990;76:285-289.
7. Roberts WM, Estrov Z, Ouspenskaia MV, et al. Measurement of residual acute leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med. 1997;336:317-323.
8. Slom TJ, Cortese MM, Gerber SI, et al. An outbreak of eosinophilic meningitis caused by Angiostrongylus cantonensis in travelers returning from the Caribbean. N Engl J Med. 2002;346:668-675.
9. Pinkel D. Selecting treatment for acute lymphoblastic leukemia. J Clin Oncol. 1996;14:4-6.
10. Mastrangelo R, Poplack D, Bleyer A, et al. Report and recommendations of the Rome workshop concerning poor prognosis acute lymphoblastic leukemia in children: biologic basis for staging, stratification, and treatment. Med Pediatr Oncol. 1986;14:191-194.
11. Mitelman F, ed. ISCN: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S Karger; 1995.
12. Sykes PJ, Neoh SH, Brisco MJ, Hughes E, Condon J, Morley AA. Quantitation of targets for PCR by use of limiting dilution. Biotechniques. 1992;13:444-449.
13. Ouspenkaia MV, Johnston DA, Roberts WM, et al. Accurate quantification of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia. 1995;9:321-328.
14. Lacronique V, Boureux A, Valle VD, et al. A TEL-JAK fusion protein with constitutive kinase activity in human leukemia. Science. 1997;278:1309-1312.
15. Peeters P, Raynaud SD, Cools J, et al. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood. 1997;90:2535-2540.